Numerous cancer cells within the body express both MHC I and MHC II, with MHC II play a key role in antigen presentation of CD4+ T-lymphocytes, the significance of CD4+ T- lymphocytes in anti-tumor immunity is increasingly recognized and valued (107). This evidence concerns the gene CD4 and neoplasm.